The Safety of Cataract Removal by Phacoemulsification Surgery in Patients Under Anti-aggregant and Coumadin Treatment

Sheba Medical Center75 enrolled

Overview

To assess the risks of intra- and postoperative bleeding tendency associated with cataract surgery by phacoemulsification in patients on coumadin and antiaggregant treatments. Design: Consecutive prospective study.

To assess the risks of intra- and postoperative bleeding tendency associated with cataract surgery by phacoemulsification technique in patients on coumadin and antiaggregant treatment Design: Consecutive prospective study.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Efficacy Complications

Interventions

cataract surgery with phacoemulsificationPROCEDURE

removal of cataract with phacoemulsification technique

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * patients who give informed consent to participate in the study Exclusion Criteria: * single eye complicated cataract

Locations (1)

Sheba Medical Center

Ramat Gan, Israel

RECRUITING

Outcomes

Primary Outcomes

safety and efficacy of cataract surgery with phacoemulsification under coumadin and antiaggregant treatment

Time frame: 3.5 years

Secondary Outcomes

other complications

Time frame: 3.5 years

Central Contacts

Ophira Salomon, MD

CONTACT

972-3-5302104 ophiras@sheba.health.gov.il

Yael Wasserzug, MD

CONTACT

972-3-5302874 yawlwasserzug@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.